dc.contributor.author | Chang, Jennifer G. | eng |
dc.contributor.author | Paulson, Christopher P. | eng |
dc.contributor.author | Smith, Rita | eng |
dc.date.issued | 2014 | eng |
dc.description.abstract | Clinical Question: Is measurement of apolipoproteins better than traditional lipid measurements for predicting cardiovascular risk? Evidence-Based Answer: Measurement of apolipoprotein B and apolipoprotein A-I is no better than traditional lipid measurements and should not be used to predict cardiovascular risk. (Strength of Recommendation: B, based on meta-analyses with conflicting results.) Apolipoprotein B and non-high-density lipoprotein cholesterol (HDL-C) predict cardiovascular risk slightly better than low-density lipoprotein cholesterol. Elevated levels of apolipoprotein A-I predict a lower risk of cardiovascular events except stroke, but not as well as elevated HDL-C levels. | eng |
dc.identifier.uri | https://hdl.handle.net/10355/44513 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2014 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network. | eng |
dc.relation.ispartofseries | American family physician, 89, no. 08 (April 2014): 662A-662B | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.source | AAFP website: http://www.aafp.org/afp/2014/0415/od2.html | eng |
dc.subject | apolipoproteins ; cardiovascular risk ; lipoprotein | eng |
dc.title | Apolipoproteins for Cardiovascular Risk Assessment | eng |
dc.type | Article | eng |